These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32953759)

  • 21. MitraClip procedure prior to left ventricular assist device implantation.
    Dogan G; Hanke JS; Ricklefs M; Chatterjee A; Feldmann C; Mashaqi B; Deniz E; Haverich A; Schmitto JD
    J Thorac Dis; 2018 Jun; 10(Suppl 15):S1763-S1768. PubMed ID: 30034850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term clinical and echocardiographic outcomes of Mitraclip therapy in patients nonresponders to cardiac resynchronization.
    Giaimo VL; Zappulla P; Cirasa A; Tempio D; Sanfilippo M; Rapisarda G; Trovato D; Grazia AD; Liotta C; Grasso C; Capodanno D; Tamburino C; Calvi V
    Pacing Clin Electrophysiol; 2018 Jan; 41(1):65-72. PubMed ID: 29139550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recurrence of Functional Versus Organic Mitral Regurgitation After Transcatheter Mitral Valve Repair: Implications from Three-Dimensional Echocardiographic Analysis of Mitral Valve Geometry and Left Ventricular Dilation for a Point of No Return.
    Buck T; Eiswirth N; Farah A; Kahlert H; Patsalis PC; Kahlert P; Plicht B
    J Am Soc Echocardiogr; 2021 Jul; 34(7):744-756. PubMed ID: 33722676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimal results immediately after MitraClip therapy or surgical edge-to-edge repair for functional mitral regurgitation: are they really stable at 4 years?
    De Bonis M; Lapenna E; Buzzatti N; La Canna G; Denti P; Pappalardo F; Schiavi D; Pozzoli A; Cioni M; Di Giannuario G; Alfieri O
    Eur J Cardiothorac Surg; 2016 Sep; 50(3):488-94. PubMed ID: 27009105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extended use of percutaneous edge-to-edge mitral valve repair beyond EVEREST (Endovascular Valve Edge-to-Edge Repair) criteria: 30-day and 12-month clinical and echocardiographic outcomes from the GRASP (Getting Reduction of Mitral Insufficiency by Percutaneous Clip Implantation) registry.
    Attizzani GF; Ohno Y; Capodanno D; Cannata S; Dipasqua F; Immé S; Mangiafico S; Barbanti M; Ministeri M; Cageggi A; Pistritto AM; Giaquinta S; Farruggio S; Chiarandà M; Ronsivalle G; Schnell A; Scandura S; Tamburino C; Capranzano P; Grasso C
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):74-82. PubMed ID: 25499300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correction of mitral regurgitation in nonresponders to cardiac resynchronization therapy by MitraClip improves symptoms and promotes reverse remodeling.
    Auricchio A; Schillinger W; Meyer S; Maisano F; Hoffmann R; Ussia GP; Pedrazzini GB; van der Heyden J; Fratini S; Klersy C; Komtebedde J; Franzen O;
    J Am Coll Cardiol; 2011 Nov; 58(21):2183-9. PubMed ID: 22078424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Italian Society of Interventional Cardiology (GIse) registry Of Transcatheter treatment of mitral valve regurgitaTiOn (GIOTTO): impact of valve disease aetiology and residual mitral regurgitation after MitraClip implantation.
    Bedogni F; Popolo Rubbio A; Grasso C; Adamo M; Denti P; Giordano A; Tusa M; Bianchi G; De Marco F; Bartorelli AL; Montorfano M; Godino C; Citro R; De Felice F; Mongiardo A; Monteforte I; Villa E; Giannini C; Crimi G; Tarantini G; Testa L; Tamburino C
    Eur J Heart Fail; 2021 Aug; 23(8):1364-1376. PubMed ID: 33742754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Minimally invasive mitral valve repair for functional mitral regurgitation in severe heart failure: MitraClip versus minimally invasive surgical approach.
    Ondrus T; Bartunek J; Vanderheyden M; Stockman B; Kotrc M; Van Praet F; Van Camp G; Lecomte P; Mo Y; Penicka M
    Interact Cardiovasc Thorac Surg; 2016 Nov; 23(5):784-789. PubMed ID: 27357467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of mortality in ischaemic versus non-ischaemic functional mitral regurgitation after successful transcatheter mitral valve repair using MitraClip: results from two high-volume centres.
    Kitamura M; Kaneko H; Schlüter M; Schewel D; Schmidt T; Alessandrini H; Kreidel F; Neuss M; Butter C; Kuck KH; Frerker C
    Clin Res Cardiol; 2019 Mar; 108(3):264-272. PubMed ID: 30097683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Left ventricular ejection fraction of < 20%: Too bad for MitraClip
    Barth S; Hautmann MB; Kerber S; Gietzen F; Reents W; Zacher M; Halbfass P; Griese DP; Schieffer B; Hamm K
    Catheter Cardiovasc Interv; 2017 Nov; 90(6):1038-1045. PubMed ID: 28568427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two-year cardiac mortality after MitraClip treatment of functional mitral regurgitation in ischemic and non-ischemic dilated cardiomyopathy.
    Godino C; Scotti A; Taramasso M; Adamo M; Russo M; Chiarito M; Melillo F; Beneduce A; Pivato CA; Arrigoni L; Toscano E; Salerno A; Cappelletti A; Magni V; Stella S; Fragasso G; Montorfano M; Agricola E; Ettori F; Margonato A; Maisano F; Colombo A
    Int J Cardiol; 2018 Oct; 269():33-39. PubMed ID: 29929931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of Percutaneous Edge-to-Edge Repair in Patients With Atrial Functional Mitral Regurgitation.
    Yoshida J; Ikenaga H; Nagaura T; Utsunomiya H; Kawai M; Makar M; Rader F; Siegel RJ; Kar S; Makkar RR; Shiota T
    Circ J; 2021 Jun; 85(7):1001-1010. PubMed ID: 33612563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early symptomatic benefit indicates long-term prognosis after transcatheter mitral valve edge-to-edge repair in functional and degenerative etiology.
    Geyer M; Keller K; Tamm AR; Born S; Bachmann K; Ruf TF; Kreidel F; Hahad O; Petrescu A; Schnitzler K; Schmitt VH; da Rocha E Silva JG; Hell MM; Schulz E; Münzel T; von Bardeleben RS
    Int J Cardiol; 2021 Dec; 344():141-146. PubMed ID: 34563598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional mitral regurgitation: structural modifications with percutaneous valve repair with MitraClip.
    Alperi A; Avanzas P; Pascual I; Adeba A; Lorca R; León V; Almendarez M; Cubero-Gallego H; Silva-Conde I; Moris C; Hernandez-Vaquero D
    Ann Transl Med; 2020 Aug; 8(15):958. PubMed ID: 32953758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Left ventricular reverse remodelling predicts long-term outcomes in patients with functional mitral regurgitation undergoing MitraClip therapy: results from a multicentre registry.
    Adamo M; Godino C; Giannini C; Scotti A; Liga R; Curello S; Fiorina C; Chiari E; Chizzola G; Abbenante A; Visco E; Branca L; Fiorelli F; Agricola E; Stella S; Lombardi C; Colombo A; Petronio AS; Metra M; Ettori F
    Eur J Heart Fail; 2019 Feb; 21(2):196-204. PubMed ID: 30549159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Percutaneous Mitral Valve Repair Vs. Stand-Alone Medical Therapy in Patients with Functional Mitral Regurgitation and Heart Failure.
    Benito-González T; Estévez-Loureiro R; Villablanca PA; Armeni P; Iglesias-Gárriz I; Minguito C; Garrote C; de Prado AP; Tundidor-Sanz E; Gualis J; Fernández-Vázquez F
    Cardiovasc Revasc Med; 2020 Jan; 21(1):52-60. PubMed ID: 31326258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Effective Regurgitation Orifice Area to Left Ventricular End-Diastolic Volume Ratio With Transcatheter Mitral Valve Repair Outcomes: A Secondary Analysis of the COAPT Trial.
    Lindenfeld J; Abraham WT; Grayburn PA; Kar S; Asch FM; Lim DS; Nie H; Singhal P; Sundareswaran KS; Weissman NJ; Mack MJ; Stone GW;
    JAMA Cardiol; 2021 Apr; 6(4):427-436. PubMed ID: 33533873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Percutaneous mitral valve repair in high-risk patients: initial experience with the Mitraclip system in Belgium.
    Vandendriessche T; Kotrc M; Tijskens M; Bartunek J; Delesie M; Paelinck BP; De Bock D; Penicka M; Stockman B; De Maeyer C; Vrints C; Vanderheyden M; Claeys MJ
    Acta Cardiol; 2014 Jun; 69(3):265-70. PubMed ID: 25029871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of Post-Procedural Change in Left Ventricle Systolic Function on Survival after Percutaneous Edge-to-Edge Mitral Valve Repair.
    Hagnäs MJ; Grasso C; Di Salvo ME; Caggegi A; Barbanti M; Scandura S; Milici A; Motta G; Bentivegna A; Sardone A; Capodicasa L; Giuffrida A; Biancari F; Mäkikallio T; Capodanno D; Tamburino C
    J Clin Med; 2021 Oct; 10(20):. PubMed ID: 34682871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk Stratification of Percutaneous Edge-to-Edge Repair by MitraClip in Patients with Mitral Regurgitation.
    Tanaka S; Imamura T; Ushijima R; Fukuda N; Ueno H; Kinugawa K
    Int Heart J; 2021 Jan; 62(1):112-118. PubMed ID: 33455987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.